Mehul Joshi has served as our Chief Financial Officer since July 2022. Mr. Joshi is an experienced finance executive with a strong background in the life sciences and technology industries. Prior to Bruker Cellular Analysis, Mr. Joshi served as Senior Vice President, Finance & Head of Global FP&A at ResMed Inc. where he oversaw the company’s global finance teams, which played an integral role in driving transformational growth, and supported multi-channel business models including pricing and profitability. Additionally, he was the Chief Financial Officer of ResMed’s Software as a Services (SaaS) business. Prior to ResMed, Mr. Joshi served in leadership positions at Gilead Sciences, where he supported the company’s exponential growth, evaluated and integrated strategic acquisitions, and implemented various tools, processes, and analytics. Mr. Joshi holds an M.B.A. in Finance & Management and a B.A. in Accounting from Rutgers University. He is also a CPA (inactive).